Partnering with Danatlas

Danatlas is committed to developing "first-in-class (FIC)" target drugs in the era of precision targeted therapy for oncology 2.0 to meet the clinical needs of patients and promote medical innovation.

With an international perspective, we comprehensively select and develop strategic partnerships on a global scale. Our world class research and development team believe in the power of partnering with premiere academic, biotech and pharmaceutical leaders to expedite drug discovery and development.

We actively seek collaboration and licensing opportunities that complement our existing portfolio and areas of research focus. We partner to accelerate development and commercialization of our existing pipeline, as well as to conduct clinical trial collaborations with our pipeline to deliver optimal treatments. To learn more about partnering opportunities, contact us at bd@danatlas.com.